<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The frequency of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is increasing in Western countries for unknown reasons, and correlates with a corresponding increase in the pre-malignant condition, <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's Oesophagus</z:e>, which raises the risk of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> by some 40- to 125-fold </plain></SENT>
<SENT sid="1" pm="."><plain>We have examined how disease progression correlates with changes in expression of the p14ARF (ARF) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor, a key regulator of the p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor pathway that is silenced in some 30% of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> overall, but for which a role in <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> is unclear </plain></SENT>
<SENT sid="2" pm="."><plain>We have used quantitative PCR, RT-PCR, methylation-specific PCR and chromatin-immunoprecipitation to examine the regulation and function of ARF in oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissue specimens and cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>We find highly significant reductions (P&lt; 0.001) in ARF expression during disease progression from <z:mpath ids='MPATH_458'>normal</z:mpath> oesophageal epithelium to <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's Oesophagus</z:e> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, with 57/76 (75%) <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> displaying undetectable levels of ARF expression </plain></SENT>
<SENT sid="4" pm="."><plain>Retention of ARF expression in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is a highly significant indicator of increased survival (P&lt; 0.001) and outperforms <z:hpo ids='HP_0000001'>all</z:hpo> clinical variables in a multivariate model </plain></SENT>
<SENT sid="5" pm="."><plain>CpG methylation as well as <z:chebi fb="0" ids="15358">histone</z:chebi> H3 methylation of lysines 9 and 27 contribute independently to ARF gene silencing in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cell lines and can be reversed by <z:chebi fb="0" ids="50131">5-aza-2'-deoxycytidine</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>The results suggest that silencing of ARF is involved in the pathogenesis of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and show that either DNA or <z:chebi fb="0" ids="15358">histone</z:chebi> methylation can provide the primary mechanism for ARF gene silencing </plain></SENT>
<SENT sid="7" pm="."><plain>Silencing of ARF could provide a useful marker for increased risk of progression and poor prognosis </plain></SENT>
</text></document>